Home › Compare › GMALY vs ABBV
GMALY yields 3.06% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, GMALY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GMALY + ABBV for your $10,000?
Genting Malaysia Berhad, together with its subsidiaries, engages in the leisure and hospitality business in Malaysia, the United Kingdom, Egypt, the United States, and the Bahamas. It operates through Leisure & Hospitality, and Properties segments. The Leisure & Hospitality segment comprises integrated resort activities, which include gaming, hotels, food and beverage, theme parks, and retail and entertainment attractions, as well as tours and travel related, and other supporting services. The Properties segment is involved in the development and sale of land and properties, as well as letting of apartment units; and property investment and management activities. It also engages in the operation of casinos; and provision of information technology and consultancy services. In addition, the company provides investment, marketing, private debt securities issuance, training, administrative, show agency, condotel, golf resort, cable car and related support, creative and art, project and construction management, offshore financing, karaoke, payment and collection agency, loyalty programme, garbage collection and disposal, sewerage, investment trading, reinsurance, and resort management services. Further, it offers electricity supply, water, liquefied petroleum gas, and other services at Genting Highlands; operates sportsbooks; owns and operates aircraft; owns sea vessels; researches and develops software; and operates a video lottery facility. The company was formerly known as Resorts World Bhd. Genting Malaysia Berhad was incorporated in 1980 and is headquartered in Kuala Lumpur, Malaysia
Full GMALY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.